Clinical role of apolipoproteins A and B

The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipopro...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Chumakova, O. V. Gritsenko, N. G. Veselovskaya, E. V. Vakhromeeva, A. A. Kozarenko
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1979
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850028318186799104
author G. A. Chumakova
O. V. Gritsenko
N. G. Veselovskaya
E. V. Vakhromeeva
A. A. Kozarenko
author_facet G. A. Chumakova
O. V. Gritsenko
N. G. Veselovskaya
E. V. Vakhromeeva
A. A. Kozarenko
author_sort G. A. Chumakova
collection DOAJ
description The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipoprotein (Apo) A, ApoB, and their ratio.Lower ApoB/ApoAI ratio values denote lower levels of cardiovascular risk.
format Article
id doaj-art-35f7bdfa22904b8eb7772f324a76aac7
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2011-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-35f7bdfa22904b8eb7772f324a76aac72025-08-20T02:59:52Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-12-0110610511110.15829/1728-8800-2011-6-105-1111691Clinical role of apolipoproteins A and BG. A. Chumakova0O. V. Gritsenko1N. G. Veselovskaya2E. V. Vakhromeeva3A. A. Kozarenko4Altay State Medical University, Barnaul; Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, KemerovoAltay State Medical University, BarnaulResearch Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo; Altay Region Cardiology Dispanser, BarnaulAltay Region Cardiology Dispanser, BarnaulAltay State Medical University, Barnaul; Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, KemerovoThe assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipoprotein (Apo) A, ApoB, and their ratio.Lower ApoB/ApoAI ratio values denote lower levels of cardiovascular risk.https://cardiovascular.elpub.ru/jour/article/view/1979atherosclerosisdyslipidemiaapoproteins
spellingShingle G. A. Chumakova
O. V. Gritsenko
N. G. Veselovskaya
E. V. Vakhromeeva
A. A. Kozarenko
Clinical role of apolipoproteins A and B
Кардиоваскулярная терапия и профилактика
atherosclerosis
dyslipidemia
apoproteins
title Clinical role of apolipoproteins A and B
title_full Clinical role of apolipoproteins A and B
title_fullStr Clinical role of apolipoproteins A and B
title_full_unstemmed Clinical role of apolipoproteins A and B
title_short Clinical role of apolipoproteins A and B
title_sort clinical role of apolipoproteins a and b
topic atherosclerosis
dyslipidemia
apoproteins
url https://cardiovascular.elpub.ru/jour/article/view/1979
work_keys_str_mv AT gachumakova clinicalroleofapolipoproteinsaandb
AT ovgritsenko clinicalroleofapolipoproteinsaandb
AT ngveselovskaya clinicalroleofapolipoproteinsaandb
AT evvakhromeeva clinicalroleofapolipoproteinsaandb
AT aakozarenko clinicalroleofapolipoproteinsaandb